Dr. Zeidan is an expert in acute myeloid leukemia and myelodysplastic syndromes, and is the author of more than 330 peer-reviewed publications. He joined the faculty at Yale in 2014 and was promoted to associate professor in 2019.
In addition to his new role, Dr. Zeidan will continue to lead the leukemia program and retain his position as assistant director of the clinical trials office.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.